Amid a volatile market backdrop, several ASX-listed companies, including gold miner Capricorn Metals, are flagged as potentially trading significantly below their intrinsic value, presenting opportunities for discerning investors.
For the first time since its aggressive accumulation began, MicroStrategy's massive Bitcoin treasury is valued below its average purchase price, incurring over $900 million in unrealized losses. The milestone tests the resilience of CEO Michael Saylor's leveraged conviction play as analysts debate the company's financial fortitude and Bitcoin's near-term path.
Former Iranian President Hassan Rouhani has issued a stark warning to the regime, urging sweeping reforms to address public grievances as internal divisions surface following a deadly crackdown on protests. The rare public criticism from within the establishment highlights growing tensions ahead of renewed nuclear talks.
The White House announces a major public-private initiative to stockpile rare earths and critical minerals, aiming to insulate U.S. defense and tech sectors from foreign supply shocks and geopolitical leverage.
A coalition of New York prosecutors warns that the landmark GENIUS Act, celebrated as a regulatory breakthrough for stablecoins, lacks critical consumer protections, potentially allowing issuers to financially benefit from frozen or disputed funds while victims struggle for restitution.
Nio's rapid growth and premium positioning make it a compelling story in the EV race, but its massive investment in a proprietary battery-swap network presents a pivotal uncertainty for investors weighing its future.
Hercules Capital (HTGC), a key lender to venture-backed companies, appears significantly undervalued by traditional metrics. With shares trading at a discount to intrinsic value and below peer multiples, the market may be overlooking its strategic role and earnings potential.
Snowflake's latest multi-year agreement with OpenAI, mirroring a similar recent deal with Anthropic, underscores a growing enterprise trend: rather than picking a single AI winner, companies are building portfolios of partnerships to access diverse models and mitigate risk.
Cboe Global Markets is exploring a revival of simplified, event-based binary options for retail investors, aiming to compete with surging prediction markets while navigating a complex regulatory landscape.
Conagra Brands launches Banquet MEGA Breakfast Bowls, a high-protein frozen line using a novel steaming method, signaling a strategic push into convenience-focused breakfast and testing investor appetite for its turnaround narrative.
IDEAYA Biosciences shares have retreated from recent highs, sparking debate among investors. While a discounted cash flow model suggests deep undervaluation, price-to-sales metrics paint a contrasting picture of a premium stock. We examine the numbers behind the volatility and what it signals for the precision oncology company's future.
Intel's bid to become a major contract chipmaker receives a significant boost as tech giants Apple and Nvidia engage in talks to shift portions of their advanced semiconductor manufacturing to Intel's U.S. facilities, challenging the long-standing dominance of TSMC and Samsung.
In his first interview as Executive Chairman, Gildo Zegna outlines a strategy of agility and direct consumer engagement to navigate global uncertainties, as the group reports resilient 2025 results driven by its flagship brand.
In a scathing letter, New York's Attorney General and top DAs accuse the federal GENIUS Act of enabling stablecoin giants to profit from illicit funds while denying restitution to victims, setting the stage for a legal and political clash.
While Wall Street chases the latest weight-loss drug headlines, Novo Nordisk's recent launch of an oral GLP-1 therapy and its entrenched insulin business present a compelling value proposition for long-term investors.
The Detroit automaker has held preliminary talks with Xiaomi and other Chinese manufacturers about potential joint ventures to build electric vehicles in the United States, a move already drawing sharp criticism from Washington lawmakers.
French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.
Following the finalization of a joint venture with investment firm CPE, Burger King's parent company RBI has reaffirmed ambitious plans to more than triple its footprint in China over the next decade, backed by a $350 million investment.
While Medtronic's shares have trailed the S&P 500 over the past year, Wall Street maintains a cautiously optimistic stance, buoyed by strong recent earnings and raised guidance.
McIlhenny Company, maker of Tabasco sauce, has sued Stoli Group USA, claiming the vodka giant's new 'Halapeño Pepper Vodka' unlawfully mimics the iconic hot sauce's packaging—a design initially proposed during failed partnership talks. The legal action intensifies as Tabasco launches its own competing spirit in collaboration with Absolut.
